- Titre
- Validating Clinical Performance, Economic, and Organisational Benefits of MSCopilot® Boost Compared to Standard Care: the MS Boost Study
- Créateurs - sans rôle
- Mikael Cohen - Centre Hospitalier Universitaire de NiceAyman Tourbah - Hôpital Raymond-PoincaréCécile DonzePierre LabaugeJérôme de SèzePhilippe GallienSeverine BieuveletLoïc CarmentPierre DrouinClarissa GorinEmma Touré CuqAlize VivesSaad ZinaïFrançois Carré - Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
- Détails de publication
- 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)
- Colloque
- 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)
- Publications en série
- MULTIPLE SCLEROSIS JOURNAL
- Éditeur
- SAGE PUBLICATIONS LTD
- Identifiants
- 99148988609311
- Unité académique
- Recherche hors université
- Langue
- English
- Type de ressource
- Conference proceeding
Acte de colloque
Validating Clinical Performance, Economic, and Organisational Benefits of MSCopilot® Boost Compared to Standard Care: the MS Boost Study
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)
MULTIPLE SCLEROSIS JOURNAL
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)
2024
Indicateurs
1 Consultations de la notice